We have isolated several H-2Kb–alloreactive cytotoxic T cell clones and analyzed their reactivity for several forms of H-2Kb. These cytotoxic T lymphocytes (CTL) were elicited by priming with a skin graft followed by in vitro stimulation using stimulator cells that express an H-2Kb molecule unable to bind CD8. In contrast to most alloreactive T cells, these CTL were able to recognize H-2Kb on the surface of the antigen processing defective cell lines RMA-S and T2. Furthermore, this reactivity was not increased by the addition of an extract containing peptides from C57BL/6 (H-2b) spleen cells, nor was the reactivity decreased by treating the target cells with acid to remove peptides bound to MHC molecules. The CTL were also capable of recognizing targets expressing the mutant H-2Kbm8 molecule. These findings suggested that the clones recognized determinants on H-2Kb that were independent of peptide. Further evidence for this hypothesis was provided by experiments in which H-2Kb produced in Drosophila melanogaster cells and immobilized on the surface of a tissue culture plate was able to stimulate hybridomas derived from these alloreactive T cells. Precursor frequency analysis demonstrated that skin graft priming, whether with skin expressing the wild-type or the mutant H-2Kb molecule, is a strong stimulus to elicit peptide-independent CTL. Moreover, reconstitution experiments demonstrated that the peptide-independent CTL clones were capable of mediating rapid and complete rejection of H-2–incompatible skin grafts. These findings provide evidence that not all allorecognition is peptide dependent.
Skip Nav Destination
Article navigation
17 March 1997
Article Contents
Article|
March 17 1997
Peptide-independent Recognition by Alloreactive Cytotoxic T Lymphocytes (CTL)
Pamela A. Smith,
Pamela A. Smith
From the *Division of Basic Immunology, Department of Medicine, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado 80206-2761; ‡the Department of Immunology and the Cancer Center, University of Colorado Health Sciences Center, Denver, Colorado; and §R.W. Johnson Pharmaceutical Research Institute, San Diego, California 92121
Search for other works by this author on:
Anders Brunmark,
Anders Brunmark
From the *Division of Basic Immunology, Department of Medicine, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado 80206-2761; ‡the Department of Immunology and the Cancer Center, University of Colorado Health Sciences Center, Denver, Colorado; and §R.W. Johnson Pharmaceutical Research Institute, San Diego, California 92121
Search for other works by this author on:
Michael R. Jackson,
Michael R. Jackson
From the *Division of Basic Immunology, Department of Medicine, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado 80206-2761; ‡the Department of Immunology and the Cancer Center, University of Colorado Health Sciences Center, Denver, Colorado; and §R.W. Johnson Pharmaceutical Research Institute, San Diego, California 92121
Search for other works by this author on:
Terry A. Potter
Terry A. Potter
From the *Division of Basic Immunology, Department of Medicine, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado 80206-2761; ‡the Department of Immunology and the Cancer Center, University of Colorado Health Sciences Center, Denver, Colorado; and §R.W. Johnson Pharmaceutical Research Institute, San Diego, California 92121
Search for other works by this author on:
Pamela A. Smith
,
Anders Brunmark
,
Michael R. Jackson
,
Terry A. Potter
From the *Division of Basic Immunology, Department of Medicine, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado 80206-2761; ‡the Department of Immunology and the Cancer Center, University of Colorado Health Sciences Center, Denver, Colorado; and §R.W. Johnson Pharmaceutical Research Institute, San Diego, California 92121
Address all correspondence to Terry A. Potter, National Jewish Medical and Research Center, 1400 Jackson St., Denver, CO 80206.
Received:
November 05 1996
Revision Received:
January 16 1997
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1997
J Exp Med (1997) 185 (6): 1023–1034.
Article history
Received:
November 05 1996
Revision Received:
January 16 1997
Citation
Pamela A. Smith, Anders Brunmark, Michael R. Jackson, Terry A. Potter; Peptide-independent Recognition by Alloreactive Cytotoxic T Lymphocytes (CTL). J Exp Med 17 March 1997; 185 (6): 1023–1034. doi: https://doi.org/10.1084/jem.185.6.1023
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement